Impact of the 8-week Administration of Tofogliflozin for Glycemic Control and Body Composition in Japanese Patients with Type 2 Diabetes Mellitus

Objective The adverse effects of selective sodium-glucose co-transporter 2 (SGLT2) inhibitors generally appear within about two or three months after treatment initiation in Japan. Therefore, we investigated the impact of tofogliflozin, a class of SGLT2 inhibitors, on glycemic control and body compo...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirose, Sachie, Nakajima, Shinsuke, Iwahashi, Yasuyuki, Seo, Akane, Takahashi, Tetsuya, Tamori, Yoshikazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173489/
https://www.ncbi.nlm.nih.gov/pubmed/27853064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173489/
https://www.ncbi.nlm.nih.gov/pubmed/27853064

Ejemplares similares